SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty

NCT ID: NCT02358447

Last Updated: 2018-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

210 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-04-30

Study Completion Date

2018-10-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

By the comparison of two operation methods navigated and non-navigated TKR with SPECT/CT we want to show wich method has the better outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With SPECT/CT we want to controll the clinical outcome of patients who underwent a navigated or a non-navigated TKR.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis X-rays; Effects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SPECT/CT before/after navigated TKR

SPECT/CT in patients before and after navigated TKR (assessment of bone tracer uptake, 3D CT component position)

TKR

Intervention Type PROCEDURE

non-navigated versus computer-navigated total knee replacement

SPECT/CT before/after conventional TKR

SPECT/CT in patients before and after conventional TKR (assessment of bone tracer uptake, 3D CT component position)

TKR

Intervention Type PROCEDURE

non-navigated versus computer-navigated total knee replacement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TKR

non-navigated versus computer-navigated total knee replacement

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Total Knee prosthesis (primary)
* \>18 years

Exclusion Criteria

* pregnancy
* lactating women
* endocrine diseases
* tumour diseases
* posttraumatic osteoarthritis of the knee
* previous infection of the knee
* medicaments which influence the metabolism of the bone
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kantonsspital Baselland Bruderholz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Tobias Hirschmann

PD Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MIchael T. Hirschmann, MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Orthop. Surgery and Traumatology, Kantonsspital Baselland - Bruderholz, Unitverstity of Basel, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kantonsspital Baselland, Bruderholz

Bruderholz, Basel-Landschaft, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

380/09

Identifier Type: OTHER

Identifier Source: secondary_id

SPECT/CT-TKR_001_MH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Outcome and Cytokine Expression After TKA
NCT03424174 ACTIVE_NOT_RECRUITING NA